Rare diseases
Investigational molecules
Locations
Back to Belgium213 clinical trials in Brugge, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
BelgiumStudy on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma
BelgiumStudy on TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Ineligible for or Refusing Platinum-Based Chemotherapy
BelgiumStudy Comparing Fedratinib with Drug Combination for Myelofibrosis in Patients Previously Treated with Ruxolitinib
BelgiumStudy Comparing TAR-200 and Chemotherapy for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer After BCG Treatment
BelgiumStudy on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery
BelgiumStudy on the Safety and Effectiveness of Epcoritamab, Venetoclax, and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
BelgiumStudy on the Safety and Effectiveness of Tovinontrine for Adults with Chronic Heart Failure with Reduced Ejection Fraction
BelgiumStudy of Secukinumab for Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis
BelgiumStudy on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma
BelgiumStudy on Ibrutinib, CD20 Ab and Venetoclax for Patients with Untreated Mantle Cell Lymphoma
BelgiumBelgiumThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on viral infections and preventive measures, including trials evaluating new vaccines against influenza and cytomegalovirus. Research also covers treatment approaches for hepatitis B and invasive fungal infections.
Innovative approaches in vaccine development and antimicrobial therapies are being tested to combat various infectious diseases.
Comprehensive research into blood cancers and solid tumors, including studies on multiple myeloma, leukemia, and gastric cancer. Novel therapeutic approaches combine targeted treatments with immunotherapy.
Advanced treatment protocols are being evaluated to improve patient outcomes in various cancer types.
Studies addressing cardiovascular disease, obesity, and type 2 diabetes. Research focuses on innovative treatments and prevention strategies for major cardiovascular events.
Trials aim to improve cardiovascular outcomes and metabolic health through novel therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
